{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:41:08Z","timestamp":1785508868643,"version":"3.56.0"},"reference-count":47,"publisher":"The Journal of Rheumatology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2025,11,5]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Dysregulated collagen turnover is implicated in systemic sclerosis (SSc) pathogenesis. We evaluated collagen turnover biomarkers in relation to the severity of fibrotic manifestations, key cytokines, and progression in SSc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Baseline and 6-month serum samples of patients with early SSc in the Collaborative National Quality and Efficacy Registry (CONQUER) cohort were analyzed for type III (pro-collagen III [PRO-C3] and collagen III M [C3M]) and type VI (pro-collagen VI [PRO-C6] and collagen VI M [C6M]) collagen turnover biomarkers, as well as C-reactive protein (CRP), interleukin 6 (IL-6), and interferon (IFN)-inducible proteins. The modified Rodnan skin score and % predicted forced vital capacity (FVC%) served as surrogate markers of disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 222 patients were included. PRO-C3 (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001) and PRO-C6 (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001) concentrations were higher in patients with diffuse disease, whereas C6M (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.04) was higher in those with interstitial lung disease. Baseline PRO-C3 (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001) and PRO-C6 (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001) positively correlated with mRSS, whereas C3M (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.03) and C6M (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.01) negatively correlated with FVC%, although the magnitude of the observed correlations was in the weak range (\n                      <jats:italic>\n                        r\n                        <jats:sub>s<\/jats:sub>\n                      <\/jats:italic>\n                      &lt; 0.4). Collagen biomarker concentrations positively correlated with CRP, IL-6, and IFN-inducible proteins at baseline. Although changes in CRP positively correlated with changes in collagen degradation protein levels (C3M and C6M), they did not correlate with changes in collagen formation protein levels (PRO-C3 and PRO-C6). In contrast, changes in IFN score showed the highest correlation with changes in PRO-C6.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PRO-C3 and PRO-C6 correlated with skin disease severity, whereas C3M and C6M correlated with lung disease severity. Collagen turnover biomarkers correlated with CRP, IL-6, and IFN-inducible proteins, providing support for the link between inflammation and fibrosis in SSc.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3899\/jrheum.2025-0532","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T13:20:18Z","timestamp":1763212818000},"page":"519-528","source":"Crossref","is-referenced-by-count":3,"title":["Association of Type III and Type VI Collagen Neoepitopes With Disease Severity in Systemic Sclerosis"],"prefix":"10.3899","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2581-7992","authenticated-orcid":false,"given":"Ali Y.","family":"Ayla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5560-6390","authenticated-orcid":false,"given":"Elana J.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"VanBuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9862-0299","authenticated-orcid":false,"given":"Flavia V.","family":"Castelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorinda","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Evnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5472-3840","authenticated-orcid":false,"given":"Tracy M.","family":"Frech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye N.","family":"Hant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"Hummers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9343-5545","authenticated-orcid":false,"given":"Kimberly S.","family":"Lakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Lebiedz-Odrobina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashima","family":"Makol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Mayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna H.","family":"McMahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry A.","family":"Molitor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9469-0919","authenticated-orcid":false,"given":"Duncan F.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Sandorfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami A.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankoor","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria K.","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Skaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia D.","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Volkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carleigh","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjin J.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8059-9978","authenticated-orcid":false,"given":"Shervin","family":"Assassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2025,11,15]]},"reference":[{"key":"2026050105301093000_53.5.519.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01692-0"},{"key":"2026050105301093000_53.5.519.2","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/art.39405","article-title":"Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease","volume":"67","author":"Suliman","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2026050105301093000_53.5.519.3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.066068"},{"key":"2026050105301093000_53.5.519.4","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.114264"},{"key":"2026050105301093000_53.5.519.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(05)70294-5"},{"key":"2026050105301093000_53.5.519.6","doi-asserted-by":"crossref","unstructured":"Nielsen MJ , Karsdal MA. Chapter 3. Type III collagen. In: Biochemistry of collagens, laminins and elastin. Karsdal MA , editor. Cambridge: Academic Press; 2016:21-30.","DOI":"10.1016\/B978-0-12-809847-9.00003-9"},{"key":"2026050105301093000_53.5.519.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-002-0306-2"},{"key":"2026050105301093000_53.5.519.8","doi-asserted-by":"crossref","unstructured":"Sun S , Karsdal MA. Chapter 6. Type VI collagen. In: Karsdal MA , editor. Biochemistry of collagens, laminins and elastin. Cambridge: Academic Press; 2016:49-55.","DOI":"10.1016\/B978-0-12-809847-9.00006-4"},{"key":"2026050105301093000_53.5.519.9","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1002\/art.39289","article-title":"Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis","volume":"67","author":"Assassi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2026050105301093000_53.5.519.10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215894"},{"key":"2026050105301093000_53.5.519.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94321-2"},{"key":"2026050105301093000_53.5.519.12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/liv.12700","article-title":"Plasma PRO-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C","volume":"35","author":"Nielsen","year":"2015","journal-title":"Liver Int"},{"key":"2026050105301093000_53.5.519.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17470-3"},{"key":"2026050105301093000_53.5.519.14","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1118-7"},{"key":"2026050105301093000_53.5.519.15","doi-asserted-by":"crossref","first-page":"e0207324","DOI":"10.1371\/journal.pone.0207324","article-title":"Serum biomarkers of collagen turnover as potential diagnostic tools in diffuse systemic sclerosis: a cross-sectional study","volume":"13","author":"Juhl","year":"2018","journal-title":"PLOS One"},{"key":"2026050105301093000_53.5.519.16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/1354750X.2019.1587509","article-title":"Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis\u2013a cross-sectional study","volume":"24","author":"Juhl","year":"2019","journal-title":"Biomarkers"},{"key":"2026050105301093000_53.5.519.17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/1756-185X.13804","article-title":"Correlation between serological biomarkers of extracellular matrix turnover and lung fibrosis and pulmonary artery hypertension in patients with systemic sclerosis","volume":"23","author":"Kubo","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"2026050105301093000_53.5.519.18","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30385-4"},{"key":"2026050105301093000_53.5.519.19","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04792-y"},{"key":"2026050105301093000_53.5.519.20","doi-asserted-by":"publisher","DOI":"10.1002\/art.38098"},{"key":"2026050105301093000_53.5.519.21","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"2026050105301093000_53.5.519.22","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01499-2021"},{"key":"2026050105301093000_53.5.519.23","first-page":"303","article-title":"The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters","volume":"5","author":"Nielsen","year":"2013","journal-title":"Am J Transl Res"},{"key":"2026050105301093000_53.5.519.24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144525"},{"key":"2026050105301093000_53.5.519.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2010.03.012"},{"key":"2026050105301093000_53.5.519.26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024753"},{"key":"2026050105301093000_53.5.519.27","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/art.41627","article-title":"Predictive significance of serum interferon-inducible protein score for response to treatment in systemic sclerosis-related interstitial lung disease","volume":"73","author":"Assassi","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2026050105301093000_53.5.519.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00765-9"},{"key":"2026050105301093000_53.5.519.29","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02026-2019"},{"key":"2026050105301093000_53.5.519.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-64233-8"},{"key":"2026050105301093000_53.5.519.31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/acr2.11165","article-title":"Enrichment strategy for systemic sclerosis clinical trials targeting skin fibrosis: a prospective, multiethnic cohort study","volume":"2","author":"Mihai","year":"2020","journal-title":"ACR Open Rheumatol"},{"key":"2026050105301093000_53.5.519.32","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207271"},{"key":"2026050105301093000_53.5.519.33","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21968"},{"key":"2026050105301093000_53.5.519.34","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21716"},{"key":"2026050105301093000_53.5.519.35","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1164\/rccm.202401-0246ED","article-title":"Enrichment strategies for systemic sclerosis-interstitial lung disease trials","volume":"209","author":"Volkmann","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026050105301093000_53.5.519.36","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026050105301093000_53.5.519.37","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1111\/liv.15365","article-title":"Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease","volume":"42","author":"Simbrunner","year":"2022","journal-title":"Liver Int"},{"key":"2026050105301093000_53.5.519.38","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1038\/cti.2013.2","article-title":"Interleukin-6: a new therapeutic target in systemic sclerosis?","volume":"2","author":"O\u2019Reilly","year":"2013","journal-title":"Clin Transl Immunology"},{"key":"2026050105301093000_53.5.519.39","doi-asserted-by":"publisher","DOI":"10.1002\/art.37742"},{"key":"2026050105301093000_53.5.519.40","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/annrheumdis-2022-eular.988","article-title":"POS0853 Effects of nintedanib on circulating biomarkers in subjects with systemic sclerosis-associated interstitial lung disease (SSc-ILD) [abstract]","volume":"81","author":"Assassi","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2026050105301093000_53.5.519.41","doi-asserted-by":"crossref","first-page":"109695","DOI":"10.1016\/j.clim.2023.109695","article-title":"Biomarkers of fibrosis, inflammation, and extracellular matrix in the phase 3 trial of tocilizumab in systemic sclerosis","volume":"254","author":"Sheng","year":"2023","journal-title":"Clin Immunol"},{"key":"2026050105301093000_53.5.519.42","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R"},{"key":"2026050105301093000_53.5.519.43","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211912"},{"key":"2026050105301093000_53.5.519.44","doi-asserted-by":"crossref","first-page":"e11782","DOI":"10.1002\/acr2.11782","article-title":"Impact of scleroderma-associated autoantibodies on clinical outcome assessments: post hoc analysis from a randomised, double-blind, placebo-controlled, phase 3 trial of tocilizumab in scleroderma","volume":"7","author":"Al Dulaijan","year":"2025","journal-title":"ACR Open Rheumatol"},{"key":"2026050105301093000_53.5.519.45","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-021-01801-0"},{"key":"2026050105301093000_53.5.519.46","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-2600(15)00048-X","article-title":"Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study","volume":"3","author":"Jenkins","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2026050105301093000_53.5.519.47","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-0980-7"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2025-0532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:31:08Z","timestamp":1777638668000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2025-0532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,1]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.3899\/jrheum.2025-0532"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2025-0532","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,15]]}}}